Changes in currency exchange, uah/eur, 02.05.19.-27.06.19
The National Bank of Ukraine (NBU) in the period from June 24 to June 27 bought $44 million in the interbank foreign exchange market, which is 8.6% more than a week earlier ($40.5 million).
According to the website of the central bank, $20 million was acquired at the best purchase and sale price (using the matching instrument), $24 million at a single rate (using the matching instrument).
In June, the National Bank bought $322.3 million compared with $203.6 million in May and $299.9 million in April.
In general, since the beginning of this year, the NBU bought $1.639 billion in the interbank market and sold $231.43 million.
National bank of ukraine’s official rates as of 02/07/19
Source: National Bank of Ukraine
Official rates of banking metals from national bank as of july 2
One troy ounce=31.10 grams
The Grand Chamber of the Supreme Court of Ukraine has sent the dispute over the Corvalolum well-known brand to the court of lowest instance for repeated hearing and partially satisfied cassation claims of the Economic Development and Trade Ministry of Ukraine and PJSC Farmak, annulling the ruling of the appeal court and the ruling of the court of lower instance.
Earlier, the Kyiv business court of appeals under the counterclaim of PrJSC Darnitsa Pharmaceutical Firm revoked the decision of the Appeals Chamber of the Ministry of Economic Development and Trade recognizing the designation Corvalolum as well-known.
“PJSC Farmak stands for civilized competition and for many years it has been defending its rights to the Corvalolum well-known brand. We defend our right only to the brand designation,” Farmak Legal Director Dmytro Taranchuk said.
He said that “the medicine itself and its components are not protected by a patent, and it is not protected in Ukraine from the point of view of intellectual property.”
“A similar medicine can be produced by any manufacturer who will prove its quality and effectiveness and undergo all the required licensing procedures. But under a different name, under its own brand,” the lawyer said.
AXA Insurance and AXA Life Insurance (both based in Kyiv) from July 1, 2019 changed their names to ARX and ARX Life, the insurance companies said in a press release.
“ARX in Latin means “fortress, castle, citadel.” The name sounds succinctly in the spirit of modern trends and reflects the main attribute of the insurance business – reliability,” the press service said.
ARX insurance company and ARX Life insurance company are the assignee of AXA Insurance and AXA Life Insurance. The companies continue working with all banks, car dealers, partners in a regional network, corporate clients, as well as with assisting companies and contractors.
The main shareholder of ARX is the Canadian holding Fairfax Limited.
According to the press release, Andriy Peretiazhko is chairman of the company’s board, Maksym Mezhebitsky is his first deputy, Viacheslav Havrylenko is deputy board chairman and since June 12 he is Director General of ARX Life.
